Results 41 to 50 of about 3,411,578 (286)

Utility of serological markers in inflammatory bowel diseases: Gadget or magic? [PDF]

, 2007
The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Although anti-Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely ...
Papp, Mária, Lakatos, Péter László, Norman, G. L., Altorjay, István   +3 more
core   +1 more source

Serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease

, 2021
sem informação231S90S90Advances-in-Inflammatory-Bowel-Diseases-Crohn's-and-Colitis Foundation's National Clinical and Research Conference2016-12-08Orlando, FL, Estados Unidossem ...
Geloneze, Bruno, Saad, Jose M., Camargo, Michel, Magro, Daniela, Guadagnini, Dioze, Ana, Carolina Vasques, areja, Jose, Carlos, Martinez A., Kotze, Paulo, Ayrizono, Maria de Lourdes, Antoniok, Calixto, Coy, Claudio   +11 more
core   +1 more source

Candidate genes colocalized to linkage regions in inflammatory bowel disease [PDF]

, 2002
Background and Aims: The genes encoding for tumor necrosis factor-alpha (TNF-alpha), epidermal growth factor receptor (EGFR) and the vitamin D receptor (VDR) are colocalized to inflammatory bowel disease-associated linkage regions on chromosomes 6, 7 and
Folwaczny, Christian, Radimayr, M., Heinzlmann, M., Borchers, R., Martin, K.   +4 more
core   +1 more source

Effect of the alkaloid indigo in DSS-induced colitis

, 2021
sem informação231S85S85Advances-in-Inflammatory-Bowel-Diseases-Crohn's-and-Colitis Foundation's National Clinical and Research Conference2016-12-08Orlando, FL, Estados Unidossem ...
Ricardo, Dunder, de-Faria, Felipe, Socca, Eduardo A., Luiz-Ferreira, Anderson, Luis, Manzo, de Almeida, Ana C.   +5 more
core   +1 more source

CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's disease

BMC Gastroenterology, 2022
Background CT enterography (CTE) is used routinely for assessment of activity and severity in Crohn's disease (CD), but there are few CTE scoring systems.
Jinlu Tong, Qi Feng, Chenpeng Zhang, Xitao Xu, Zhihua Ran   +4 more
doaj   +1 more source

Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort

, 2014
BACKGROUND AND AIMS Limited data from large cohorts are available on tumor necrosis factor (TNF) antagonists (infliximab, adalimumab, certolizumab pegol) switch over time.
Safroneeva, Ekaterina, Safroneeva, E., Rogler, Gerhard, Schöpfer, Alain, Pittet, V., Vavricka, Stephan, Pittet, Valérie, Fournier, N., Hiroz, Philippe, Swiss Inflammatory Bowel Disease Cohort Study Group, Rogler, G., Fournier, Nicolas, Schoepfer, A.M., Swiss Inflammatory Bowel Diseases Cohort Study Group, The, Vavricka, S.R., Juillerat, Pascal, Hiroz, P., Vavricka, Stephan R, Schoepfer, Alain M, Fournier N, Rogler G, Vavricka SR, Schoepfer AM, Hiroz P, Safroneeva E, Pittet V   +25 more
core   +1 more source

Therapy with lupeol, a natural pentacyclic triterpenoid, attenuates intestinal inflammation in rat

, 2021
sem informação231S83S84Advances-in-Inflammatory-Bowel-Diseases-Crohn's-and-Colitis Foundation's National Clinical and Research Conference2016-12-08Orlando, FL, Estados Unidossem ...
Barboza-Filho, Jose M., Manzo, Luis, de-Faria, Felipe, Maia, Gabriela L., Regina, Souza-Brito Alba, Socca, Eduardo A., Dunder, Ricardo, Luiz-Ferreira, Anderson, de Almeida, Ana C.   +8 more
core   +1 more source

Recent trends in the epidemiology of inflammatory bowel diseases: up or down? [PDF]

, 2006
Inflammatory bowel disease (IBD) is traditionally considered to be common in the Western world, and its incidence has sharply increased since the early 1950s.
Lakatos, Péter László
core   +1 more source

Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta‐analysis

Journal of Cachexia, Sarcopenia and Muscle, 2023
The prevalence of sarcopenia and its clinical predictors and clinical impact vary among kidney transplant recipients (KTRs), in part because of different diagnostic criteria.
Jin‐Zhi Zhang, Wei Shi, Min Zou, Qi‐Shan Zeng, Yue Feng, Zhen‐Yi Luo, Hua‐Tian Gan   +6 more
doaj   +1 more source

Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review

Canadian Journal of Gastroenterology and Hepatology, 2015
There is increasing interest in the concept of ‘treat-to-target’ in inflammatory bowel disease as a mechanism to standardize management and prevent complications. While clinical, radiographic and endoscopic treatment end points will figure prominently in
Travis B Murdoch, Sarah O’Donnell, Mark S Silverberg, Remo Panaccione   +3 more
doaj   +1 more source